Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 11-2010 | 08-2010 | 05-2010 | 02-2010 | 11-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12 | -12 | -332 | -164 | -298 |
| Depreciation Amortization | 69 | 33 | 114 | 83 | 51 |
| Accounts receivable | 131 | -22 | -314 | -318 | 116 |
| Other Working Capital | -14 | -228 | 83 | -92 | 276 |
| Other Operating Activity | -96 | 30 | 211 | 258 | -172 |
| Operating Cash Flow | $78 | $-199 | $-237 | $-233 | $-26 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 100 | 100 | 100 |
| PPE Investments | -64 | -7 | -316 | -296 | -250 |
| Purchase Sale Intangibles | -74 | -25 | -54 | -15 | -4 |
| Other Investing Activity | -74 | -25 | -54 | -15 | -5 |
| Investing Cash Flow | $-138 | $-32 | $-269 | $-210 | $-155 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -22 | -11 | -42 | -31 | -21 |
| Common Stock Issued | N/A | N/A | 10 | 10 | 10 |
| Financing Cash Flow | $-22 | $-11 | $-32 | $-22 | $-11 |
| Exchange Rate Effect | -1 | -1 | -2 | -1 | -1 |
| Beginning Cash Position | 1,055 | 1,055 | 1,596 | 1,596 | 1,596 |
| End Cash Position | 972 | 813 | 1,055 | 1,130 | 1,403 |
| Net Cash Flow | $-83 | $-242 | $-541 | $-466 | $-192 |
| Free Cash Flow | |||||
| Operating Cash Flow | 78 | -199 | -237 | -233 | -26 |
| Capital Expenditure | -64 | -7 | -316 | -296 | -250 |
| Free Cash Flow | 14 | -206 | -553 | -529 | -276 |